Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Black Friday Sale
    Black Friday Sale
    HomeNewsBusinessMoneycontrol ResearchSun Pharma: Innovative drugs are near-term growth drivers

    Sun Pharma: Innovative drugs are near-term growth drivers

    Sun Pharma’s top line growth is steady. Innovative medicines to act as growth tonic, as the US generics business remains soft. The stock valuation is justified.

    Anubhav Sahu
    August 01, 2025 / 10:52 IST
    Key factors to watch are tariffs & new product launch
    • PRO Panorama

      Moneycontrol Pro Panorama | The tyranny and tricks of outlooks

      Dec 12, 2025 / 03:41 PM IST

      In Moneycontrol's Pro Panorama December 12 edition: IPO window opens but large firms dominate opportunities, private sector domina...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | Samvat 2082: The Will to Rise

      Oct 18, 2025 / 10:00 AM IST

      After a turbulent Samvat 2081, the markets step into the new year not with fireworks but with quiet resolve and the will to rise

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More